A FtsZ Inhibitor That Can Utilize Siderophore-Ferric Iron Uptake Transporter Systems for Activity against Gram-Negative Bacterial Pathogens.

Bryan, Eric J; Qiao, Qi; Wang, Yuxuan; Roberge, Jacques Y; LaVoie, Edmond J; Pilch, Daniel S

Bryan, Eric J; Qiao, Qi; Wang, Yuxuan; Roberge, Jacques Y; LaVoie, Edmond J; Pilch, Daniel S.

Afiliación

Bryan EJ; Department of Pharmacology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
Qiao Q; Department of Molecular Design and Synthesis, Rutgers University Biomedical Innovation Cores, Piscataway, NJ 08854, USA.
Wang Y; Department of Pharmacology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
Roberge JY; Department of Molecular Design and Synthesis, Rutgers University Biomedical Innovation Cores, Piscataway, NJ 08854, USA.
LaVoie EJ; Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
Pilch DS; Department of Pharmacology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.

Antibiotics (Basel) ; 13(3)2024 Feb 22.

Article en En | MEDLINE | ID: mdl-38534644

Palabras clave

Acinetobacter baumannii; FtsZ inhibitor-antibiotic synergy; Klebsiella pneumoniae; antibiotic uptake; antibiotic-siderophore conjugate

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Antibiotics (Basel) Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos